6533b824fe1ef96bd1280234
RESEARCH PRODUCT
PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars: The Case of Epoetine, Granulocyte-Colony Stimulating Factor, and Growth Hormones
A. FrenzelN. SchmidtJ. Grahlsubject
medicine.medical_specialtyEndocrinologyInternal medicineHealth PolicymedicinePublic Health Environmental and Occupational HealthBiosimilarBiologyGrowth hormoneGranulocyte colony-stimulating factorMarket penetration| year | journal | country | edition | language | 
|---|---|---|---|---|
| 2012-11-01 | Value in Health |